{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:45:08Z","timestamp":1787165108211,"version":"build-2736575974"},"reference-count":125,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Driving is a coordinated psychomotor activity that involves reaction time, attention, and decision-making. Psychoactive substances such as 2-phenylethylamine (PEA) derivatives and opioids may affect these functions and contribute to traffic safety. This systematic review revealed the effects of the selected PEA derivatives and opioids on psychomotor performance among drivers and potential road safety outcomes. Methods: The review followed PRISMA 2020 standards. Using the PICO method, we conducted a systematic search in Embase, PubMed, and Web of Science (2000\u20132025). Included studies involved adult participants and quantified the effect of PEA derivatives or opioids on driving-related psychomotor function. Thirty-one articles, such as randomized controlled trials, crossover studies, observational studies, and simulator-based studies, were examined. Risk of bias was evaluated using the RoB2 tool. Results: Evidence indicates therapeutic amphetamine and methylphenidate doses can enhance psychomotor function and safety in patients with ADHD. Recreational or high-dose use of methamphetamine and MDMA is associated with impaired coordination, variable speed, and increased impulsivity. Opioid effects are tolerance- and dose-dependent. Small therapeutic doses of fentanyl in chronically treated patients do not notably impair driving. On the other hand, methadone and tramadol commonly cause somnolence, retardation of reaction, and increased accident risk. Conclusions: The impact of opioids and PEA derivatives on psychomotor function is multifactorial, depending on dose, time, route of administration, and patient status. These substances can either improve or impair driving safety. The findings confirm the need for individual-specific pharmacotherapy treatment. They also highlight the importance of further studies to formulate evidence-based clinical and legislative guidelines.<\/jats:p>","DOI":"10.3390\/ph18101555","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:29:38Z","timestamp":1760599778000},"page":"1555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1151-2332","authenticated-orcid":false,"given":"Kacper","family":"\u017be\u0142abowski","sequence":"first","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2157-103X","authenticated-orcid":false,"given":"Kamil","family":"Biedka","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Division of Pathophysiology, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Pichowicz","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8925-3260","authenticated-orcid":false,"given":"Maria","family":"Sterkowicz","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0612-6280","authenticated-orcid":false,"given":"Izabela","family":"Radzka","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacy","family":"Ilski","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8752-2321","authenticated-orcid":false,"given":"Micha\u0142","family":"Weso\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Division of Pathophysiology, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4595-7748","authenticated-orcid":false,"given":"Kacper","family":"Wojtysiak","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktor","family":"Petrov","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9150-3768","authenticated-orcid":false,"given":"Dawid","family":"\u015alebioda","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1663-4162","authenticated-orcid":false,"given":"Maciej","family":"Rz\u0105ca","sequence":"additional","affiliation":[{"name":"Scientific Society for Psychopharmacology, Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Ch\u0142opa\u015b-Konowa\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Division of Molecular Techniques, Wroclaw Medical University, Sklodowskiej-Curie 52, 50-369 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100224","DOI":"10.1016\/j.fsisyn.2022.100224","article-title":"Driving under the influence of drugs: Correlation between blood psychoactive drug concentrations and cognitive impairment. A narrative review taking into account forensic issues","volume":"4","author":"Blandino","year":"2022","journal-title":"Forensic Sci. Int. Synerg."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ryu, I.S., Kim, O.-H., Kim, J.S., Sohn, S., Choe, E.S., Lim, R.-N., Kim, T.W., Seo, J.-W., and Jang, E.Y. (2021). Effects of \u03b2-Phenylethylamine on Psychomotor, Rewarding, and Reinforcing Behaviors and Affective State: The Role of Dopamine D1 Receptors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179485"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Krombholz, S., Thomas, A., Piper, T., Lagojda, A., K\u00fchne, D., and Thevis, M. (2021). Urinary phenylethylamine metabolites as potential markers for sports drug testing purposes. Biomed. Chromatogr., 36.","DOI":"10.1002\/bmc.5274"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"\u017be\u0142abowski, K., Petrov, W., \u015alebioda, D., Rusinek, M., Biedka, K., B\u0142aszczyk, K., Weso\u0142owski, M., Wojtysiak, K., Sroka, M., and Ratka, Z. (2025). Holistic Management of Adult ADHD with a History of Addiction: Emphasis on Low-Addiction-Risk Psychopharmacotherapy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186470"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: Geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021","volume":"118","author":"Friedman","year":"2023","journal-title":"Addiction"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/injuryprev-2020-044015","article-title":"Risk factors associated with driving under the influence of drugs in the USA","volume":"27","author":"Rudisill","year":"2021","journal-title":"Inj. Prev."},{"key":"ref_8","first-page":"6","article-title":"Phenylethylamine modulation of affect: Therapeutic and diagnostic implications","volume":"7","author":"Sabelli","year":"2006","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2010.07.013","article-title":"2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb\/c mice","volume":"57","author":"Sengupta","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-023-06775-1","article-title":"Recognition of methamphetamine and other amines by trace amine receptor TAAR1","volume":"624","author":"Liu","year":"2023","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, Y.J., Kim, H.R., Lee, C.Y., Hyun, S.A., Ko, M.Y., Lee, B.S., Hwang, D.Y., and Ka, M. (2020). 2-Phenylethylamine (PEA) Ameliorates Corticosterone-Induced Depression-Like Phenotype via the BDNF\/TrkB\/CREB Signaling Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239103"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pbb.2005.10.004","article-title":"2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice","volume":"82","author":"Kitanaka","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/jpet.107.134247","article-title":"Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: Implication for modulatory roles of trace amines in brain","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/cap.2019.0043","article-title":"New Formulations of Stimulants: An Update for Clinicians","volume":"29","author":"Steingard","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","article-title":"The Potential for Misuse and Abuse of Medications in ADHD: A Review","volume":"126","author":"Clemow","year":"2014","journal-title":"Postgrad. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1007\/s00213-022-06261-y","article-title":"Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled studies","volume":"239","author":"Lee","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_17","first-page":"S551","article-title":"Methylphenidate Attenuates Signs of Evoked Neuropathic Pain in Animal Model","volume":"72","author":"Vaculin","year":"2023","journal-title":"Physiol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00213-024-06686-7","article-title":"Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: A review","volume":"241","author":"Iv","year":"2024","journal-title":"Psychopharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Parlatini, V., Bellato, A., Murphy, D., and Cortese, S. (2024). From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD. Neurosci. Biobehav. Rev., 164.","DOI":"10.1016\/j.neubiorev.2024.105841"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/cpt.2368","article-title":"Methadone Destabilizes Cardiac Repolarization During Sleep","volume":"110","author":"Solhjoo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jchromb.2007.11.042","article-title":"Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): Involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography\u2013mass spectrometry","volume":"862","author":"Ewald","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425255.2020.1749262","article-title":"MDMA interactions with pharmaceuticals and drugs of abuse","volume":"16","author":"Papaseit","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.1995","article-title":"MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review with Meta-Analysis","volume":"62","author":"Smith","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"ref_24","first-page":"125","article-title":"MDMA to Treat PTSD in Adults","volume":"51","author":"Latimer","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"ref_25","first-page":"254","article-title":"[MDMA-assisted therapy for PTSD]","volume":"110","author":"Thorarinsdottir","year":"2024","journal-title":"Laeknabladid"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109294","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: The forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.8b00215","article-title":"Dark Classics in Chemical Neuroscience: Mescaline","volume":"9","author":"Cassels","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2741\/4918","article-title":"Synesthesia, hallucination, and autism","volume":"26","author":"Gennaro","year":"2021","journal-title":"Front. Biosci.-Landmark"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-199651050-00002","article-title":"Opioid Analgesics: Comparative Features and Prescribing Guidelines","volume":"51","author":"Cherny","year":"1996","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.3390\/curroncol31120561","article-title":"Methadone in Cancer-Related Neuropathic Pain: A Narrative Review","volume":"31","author":"Ragaban","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","article-title":"Methadone: Applied pharmacology and use as adjunctive treatment in chronic pain","volume":"80","author":"Brown","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in Tramadol: Pharmacology, Metabolism, and Misuse","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth. Analg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-019-00623-5","article-title":"Revisiting Tramadol: A Multi-Modal Agent for Pain Management","volume":"33","author":"Barakat","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","article-title":"Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures","volume":"131","author":"Hassamal","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e28795","DOI":"10.1016\/j.heliyon.2024.e28795","article-title":"Fentanyl and its derivatives: Pain-killers or man-killers?","volume":"10","author":"Patocka","year":"2024","journal-title":"Heliyon"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpainsymman.2005.01.009","article-title":"Fentanyl","volume":"29","author":"Stanley","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/d41586-024-01361-5","article-title":"Neural pathways for reward and relief promote fentanyl addiction","volume":"630","author":"Heilig","year":"2024","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Masud, M., Chan, H., Erdelyi, S., Yuan, Y., and Brubacher, J.R. (2020). Epidemiology of drug driving: Protocol from a national Canadian study measuring levels of cannabis, alcohol and other substances in injured drivers. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09176-5"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3923\/tmr.2016.20.27","article-title":"Incidence of substance abuse among cab-drivers involved in non fatal accidents","volume":"11","author":"Aglan","year":"2016","journal-title":"Trends Med. Res."},{"key":"ref_46","unstructured":"Thomas, F.D., Darrah, J., Graham, L., Berning, A., Blomberg, R., Finstad, K., Griggs, C., Crandall, M., Schulman, C., and Kozar, R. (2025, July 27). Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users, Available online: https:\/\/www.nhtsa.gov\/sites\/nhtsa.gov\/files\/2022-12\/Alcohol-Drug-Prevalence-Among-Road-Users-Report_112922-tag.pdf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1556-4029.2012.02055.x","article-title":"Driving Under the Influence of Amphetamine-Like Drugs","volume":"57","author":"Musshoff","year":"2012","journal-title":"J. Forensic Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"111479","DOI":"10.1016\/j.forsciint.2022.111479","article-title":"Gender differences in driving under the influence of psychoactive drugs: Evidence mapping of real case studies and meta-analysis","volume":"341","author":"Pelletti","year":"2022","journal-title":"Forensic Sci. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1556-4029.15179","article-title":"Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies","volume":"68","author":"McGrane","year":"2022","journal-title":"J. Forensic Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00213-011-2184-9","article-title":"MDMA and methamphetamine: Some paradoxical negative and positive mood changes in an acute dose laboratory study","volume":"215","author":"Parrott","year":"2011","journal-title":"Psychopharmacology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.15288\/jsad.22-00050","article-title":"The Incidence and Temporal Patterns of Use of Amphetamine-Type Stimulant Use in Traffic-Related Ambulance Attendances From 2015 to 2020 in Victoria, Australia","volume":"84","author":"Hayley","year":"2023","journal-title":"J. Stud. Alcohol Drugs"},{"key":"ref_52","first-page":"25","article-title":"Amphetamines in wastewater of the city Pozna\u0144 (Poland)\u2013estimation of drug abuse","volume":"71","author":"Nowicki","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0269881112472564","article-title":"Personality and the acute subjective effects of d-amphetamine in humans","volume":"27","author":"Kirkpatrick","year":"2013","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jat\/bkae024","article-title":"Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment","volume":"48","author":"Heide","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00213-003-1714-5","article-title":"Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety","volume":"173","author":"Brookhuis","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Steinkellner, T., Freissmuth, M., Sitte, H.H., and Montgomery, T. (2011). The ugly side of amphetamines: Short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d), methamphetamine and d-amphetamine. Biol. Chem., 392.","DOI":"10.1515\/bc.2011.016"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lowe, H., Toyang, N., Steele, B., Grant, J., Ali, A., Gordon, L., and Ngwa, W. (2022). Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Molecules, 27.","DOI":"10.3390\/molecules27082520"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10826084.2020.1837167","article-title":"MDMA Use by Paris Medical Students: Prevalence and Characteristics","volume":"56","author":"Bazin","year":"2021","journal-title":"Subst. Use Misuse"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/08897077.2018.1528493","article-title":"3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth","volume":"40","author":"Lake","year":"2019","journal-title":"Subst. Abus."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/10870547241226634","article-title":"A randomized, phase 3, double-blind, crossover comparison of multilayer, extended-release methylphenidate (PRC-063), and lisdexamfetamine in the driving performance of young adults with ADHD","volume":"28","author":"Madaan","year":"2024","journal-title":"J. Atten. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1177\/1087054716658126","article-title":"Driving With ADHD: Performance Effects and Environment Demand in Traffic","volume":"24","author":"Randell","year":"2016","journal-title":"J. Atten. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/7854_2022_330","article-title":"Current Pharmacological Treatments for ADHD","volume":"57","author":"Groom","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e704-10","DOI":"10.1542\/peds.2005-2947","article-title":"Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit\/hyperactivity disorder","volume":"118","author":"Cox","year":"2006","journal-title":"Pediatrics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/postgradmedj-2021-140991","article-title":"Prevalence of methylphenidate use by Master of Medicine students at a South African university","volume":"98","author":"Louw","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.euroneuro.2014.06.006","article-title":"Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: A systematic review","volume":"24","author":"Gobbo","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_66","first-page":"337","article-title":"11-Year Study of Fentanyl in Driving Under the Influence of Drugs Casework","volume":"46","author":"Bierly","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0885-3924(02)00539-0","article-title":"Driving ability under long-term treatment with transdermal fentanyl","volume":"25","author":"Sabatowski","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jat\/bkaa105","article-title":"Fentanyl and Driving Impairment","volume":"45","author":"Rohrig","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1526-4637.2004.04005.x","article-title":"The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions","volume":"5","author":"Menefee","year":"2004","journal-title":"Pain Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jat\/bkab085","article-title":"Fentanyl, Acetylfentanyl and Carfentanil in Impaired Driving Cases: A Review of 270 Cases","volume":"45","author":"Kiely","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000019004","article-title":"Cognitive-Motor Performance of Methadone-Maintained Patients","volume":"6","author":"Specka","year":"2000","journal-title":"Eur. Addict. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.08.012","article-title":"A randomized controlled trial of the effects of working memory training in methadone maintenance patients","volume":"156","author":"Rass","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pain.2005.12.019","article-title":"Effect of chronic nonmalignant pain on highway driving performance","volume":"122","author":"Veldhuijzen","year":"2006","journal-title":"PAIN"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s004820050091","article-title":"Opioide und fahrtuchtigkeit","volume":"11","author":"Strumpf","year":"1997","journal-title":"Schmerz"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"109055","DOI":"10.1016\/j.drugalcdep.2021.109055","article-title":"Driving while under the influence of hallucinogens: Prevalence, correlates, and risk profiles","volume":"228","author":"Cano","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tirri, M., Bilel, S., Arf\u00e8, R., Corli, G., Marchetti, B., Bernardi, T., Boccuto, F., Serpelloni, G., Botr\u00e8, F., and De-Giorgio, F. (2022). Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.875722"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31887\/DCNS.2019.21.3\/pharvey","article-title":"Domains of cognition and their assessment","volume":"21","author":"Harvey","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"104482","DOI":"10.1016\/j.apergo.2025.104482","article-title":"Working memory capacity improves checking performance for errors on a simulated rail control task","volume":"125","author":"McMullan","year":"2025","journal-title":"Appl. Ergon."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.trf.2019.10.002","article-title":"Cognitive function and driving in middle adulthood: Does age matter?","volume":"66","author":"Ledger","year":"2019","journal-title":"Transp. research. Part F Traffic Psychol. Behav."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.trf.2025.01.036","article-title":"The relationship between brain structure and function and driving performance in older adults with and without cognitive impairment: A systematic review","volume":"109","author":"Branch","year":"2025","journal-title":"Transp. research. Part F Traffic Psychol. Behav."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107602","DOI":"10.1016\/j.aap.2024.107602","article-title":"Modeling distracted driving behavior considering cognitive processes","volume":"202","author":"Zhu","year":"2024","journal-title":"Accid. Anal. Prev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107071","DOI":"10.1016\/j.aap.2023.107071","article-title":"On the importance of working memory in the driving safety field: A systematic review","volume":"187","author":"Zhang","year":"2023","journal-title":"Accid. Anal. Prev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Ben-Artzi, I., Luria, R., and Shahar, N. (2022). Working memory capacity estimates moderate value learning for outcome-irrelevant features. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-21832-x"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.aap.2013.06.032","article-title":"Investigating the influence of working memory capacity when driving behavior is combined with cognitive load: An LCT study of young novice drivers","volume":"62","author":"Ross","year":"2014","journal-title":"Accid. Anal. Prev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/eng-2020-0004","article-title":"Drivers \u2019reaction time research in the conditions in the real traffic","volume":"10","author":"Tarkowski","year":"2020","journal-title":"Open Eng."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02984660","article-title":"Functional brain mapping of actual car-driving using [18F]FDG-PET","volume":"20","author":"Jeong","year":"2006","journal-title":"Ann. Nucl. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1167\/1.2.3","article-title":"Driving in the future: Temporal visuomotor adaptation and generalization","volume":"1","author":"Cunningham","year":"2001","journal-title":"J. Vis."},{"key":"ref_88","unstructured":"United Nations (2025, March 11). Single Convention on Narcotic Drugs (1961) 1961, Available online: https:\/\/libr.sejm.gov.pl\/tek01\/txt\/onz\/1961b.html."},{"key":"ref_89","unstructured":"Regulation of the Minister of Health (2025, March 11). Rozporz\u0105dzenie Ministra Zdrowia z dnia 17 Kwietnia 2023 r. w Sprawie Wykazu Substancji Psychotropowych, \u015brodk\u00f3w Odurzaj\u0105cych oraz Nowych Substancji Psychoaktywnych. Dziennik Ustaw, Available online: https:\/\/isap.sejm.gov.pl\/isap.nsf\/DocDetails.xsp?id=WDU20230000744."},{"key":"ref_90","unstructured":"Polska, S.N.R. (2025, March 11). Supreme Court of Poland. Uchwa\u0142a S\u0105du Najwy\u017cszego z dnia 27 lutego 2007 r., sygn. akt I KZP 36\/06. S\u0105d Najwy\u017cszy. Available online: https:\/\/www.sn.pl\/sites\/orzecznictwo\/Orzeczenia1\/I%20KZP%2036-06.pdf."},{"key":"ref_91","unstructured":"Act on the Professions of Physician and Dentist (2025, March 11). Ustawa z dnia 5 Grudnia 1996 r. o Zawodach Lekarza i Lekarza Dentysty. Dz.U. 1997 nr 28 poz. 152. Dziennik Ustaw, Available online: https:\/\/isap.sejm.gov.pl\/isap.nsf\/DocDetails.xsp?id=wdu19970280152."},{"key":"ref_92","unstructured":"Polska, R. (2025, March 11). Polish Penal Code. Kodeks Karny. Dziennik Ustaw. Dz.U. 1997 nr 88 poz. 553, June 1997, Available online: https:\/\/isap.sejm.gov.pl\/isap.nsf\/DocDetails.xsp?id=WDU1997088055."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"112931","DOI":"10.1016\/j.celrep.2023.112931","article-title":"Prediction errors drive dynamic changes in neural patterns that guide behavior","volume":"42","year":"2023","journal-title":"Cell Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-012-2744-7","article-title":"Effects of d-amphetamine on simulated driving performance before and after sleep deprivation","volume":"222","author":"Vadeby","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1087054708322986","article-title":"Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine","volume":"12","author":"Kay","year":"2009","journal-title":"J. Atten. Disord."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00213-004-2061-x","article-title":"The effects of dexamphetamine on simulated driving performance","volume":"179","author":"Silber","year":"2005","journal-title":"Psychopharmacology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-006-0410-7","article-title":"The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance","volume":"187","author":"Silber","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-012-2805-y","article-title":"Driving on ice: Impaired driving skills in current methamphetamine users","volume":"225","author":"Bosanquet","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.aap.2011.08.017","article-title":"The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: A simulator study","volume":"45","author":"Stough","year":"2012","journal-title":"Accid. Anal. Prev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsr.2005.01.001","article-title":"Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder","volume":"36","author":"Barkley","year":"2005","journal-title":"J. Saf. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00702-007-0834-1","article-title":"Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit\/hyperactivity disorder (ADHD)","volume":"115","author":"Sobanski","year":"2008","journal-title":"J. Neural Transm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3182496dc5","article-title":"Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit\/hyperactivity disorder","volume":"32","author":"Cox","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/JCP.0000000000000174","article-title":"Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD","volume":"34","author":"Verster","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/02698811241286715","article-title":"Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study","volume":"38","author":"Aitken","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1520\/JFS15579J","article-title":"The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers","volume":"47","author":"Samyn","year":"2002","journal-title":"J. Forensic Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-011-2497-8","article-title":"MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid","volume":"222","author":"Bosker","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-006-0434-z","article-title":"MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function","volume":"187","author":"Kuypers","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.aap.2009.04.015","article-title":"Risky car following in abstinent users of MDMA","volume":"42","author":"Dastrup","year":"2010","journal-title":"Accid. Anal. Prev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF03017791","article-title":"General anesthesia does not impair simulator driving skills in volunteers in the immediate recovery period\u2014A pilot study","volume":"50","author":"Sinclair","year":"2003","journal-title":"J. Can. D\u2019anesthesie [Can. J. Anaesth.]"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/JCP.0000000000001101","article-title":"Driving Simulator Performance After Administration of Analgesic Doses of Ketamine With Dexmedetomidine or Fentanyl","volume":"39","author":"Hayley","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The Neurobiology of Opioid Dependence: Implications for Treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1152\/jn.00444.2023","article-title":"Sustained fentanyl exposure inhibits neuronal activity in dissociated striatal neuronal-glial cocultures through actions independent of opioid receptors","volume":"132","author":"Yarotskyy","year":"2024","journal-title":"J. Neurophysiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lam, D., Sebastian, A., Bogguri, C., Hum, N.R., Ladd, A., Cadena, J., Valdez, C.A., Fischer, N.O., Loots, G.G., and Enright, H.A. (2022). Dose-dependent consequences of sub-chronic fentanyl exposure on neuron and glial co-cultures. Front. Toxicol., 4.","DOI":"10.3389\/ftox.2022.983415"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002826-199112000-00001","article-title":"Neurobiological Mechanisms of Opioid Tolerance and Dependence","volume":"14","author":"Collin","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/SAR.S484167","article-title":"Synaptic Structure and Transcriptomic Profiling of Reward and Sensory Brain Areas in Male Mice of Fentanyl Addiction","volume":"15","author":"Feng","year":"2024","journal-title":"Subst. Abus. Rehabil."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Bramness, J.G., Gundersen, \u00d8.H., Guterstam, J., Rognli, E.B., Konstenius, M., L\u00f8berg, E.M., Medhus, S., Tanum, L., and Franck, J. (2012). Amphetamine-induced psychosis\u2014A separate diagnostic entity or primary psychosis triggered in the vulnerable?. BMC Psychiatry, 12.","DOI":"10.1186\/1471-244X-12-221"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000101548","article-title":"Influence of peak and trough levels of opioid maintenance therapy on driving aptitude","volume":"13","author":"Baewert","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000076118","article-title":"Maintenance therapy with synthetic opioids and driving aptitude","volume":"10","author":"Schindler","year":"2004","journal-title":"Eur. Addict. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/JCP.0000000000001077","article-title":"Pharmacokinetics of single doses of methadone and buprenorphine in blood and oral fluid in healthy volunteers and correlation with effects on psychomotor and cognitive functions","volume":"39","author":"Strand","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e63954","DOI":"10.7554\/eLife.63954","article-title":"Risk of motor vehicle collisions after methadone use","volume":"10","author":"Yang","year":"2021","journal-title":"eLife"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2003.08.002","article-title":"The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving","volume":"72","author":"Dietze","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e256379","DOI":"10.1001\/jamanetworkopen.2025.6379","article-title":"Prevalence of impairing substance use in injured drivers","volume":"8","author":"Brubacher","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.1238","article-title":"The effect of d-methamphetamine on simulated driving performance","volume":"27","author":"Silber","year":"2012","journal-title":"Hum. Psychopharmacol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/10\/1555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:40:30Z","timestamp":1760600430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/10\/1555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":125,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ph18101555"],"URL":"https:\/\/doi.org\/10.3390\/ph18101555","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}